Cargando…

Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?

Detalles Bibliográficos
Autores principales:	Dudreuilh, Caroline, Moutzouris, Dimitrios-Anestis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the National Kidney Foundation, Inc. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320864/ https://www.ncbi.nlm.nih.gov/pubmed/32603711 http://dx.doi.org/10.1053/j.ajkd.2020.06.006

Ejemplares similares

IgG SARS-CoV-2 Antibodies Persist at Least for 10 Months in Patients on Hemodialysis
por: Dudreuilh, Caroline, et al.
Publicado: (2021)

In Reply to ‘Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?’
por: De Vriese, An S., et al.
Publicado: (2020)

De-isolation of COVID-19–positive hemodialysis patients in the outpatient setting: a single-center experience
por: Dudreuilh, Caroline, et al.
Publicado: (2020)

Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays
por: Tian, Ying, et al.
Publicado: (2020)

SARS-CoV-2 serological cross-reactivity with autoantibodies
por: Choy, Kay Weng
Publicado: (2021)

Serological assays for delayed SARS-CoV-2 case identification
por: Choy, Kay Weng
Publicado: (2020)

Cadaveric donor specimens and serological testing for SARS-CoV-2
por: Yeang, Malinna, et al.
Publicado: (2022)

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

Challenges in interpreting SARS-CoV-2 serological results in African countries
por: Nkuba Ndaye, Antoine, et al.
Publicado: (2021)

Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020)

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
por: Pallett, Scott J C, et al.
Publicado: (2021)

Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
por: Perez-Saez, Javier, et al.
Publicado: (2021)

Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
por: Lucchini, Matteo, et al.
Publicado: (2020)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

SARS-CoV-2/COVID-19: Evolution in the Caribbean islands
por: Escobedo, Angel A., et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Post-SARS-CoV-2-vaccine shoulder pain: Is it relevant to the vaccine injection? – Correspondence
por: Deng, Zhenhan, et al.
Publicado: (2022)

Outcomes From Infections With Variant Strains of SARS-CoV-2 Among Patients Receiving Maintenance Hemodialysis
por: Wand, Ori, et al.
Publicado: (2021)

SARS-CoV-2 in semen: Potential for sexual transmission in COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19
por: Kim, Min-Chul, et al.
Publicado: (2021)

SARS-CoV-2 viral load predicts COVID-19 mortality
por: Pujadas, Elisabet, et al.
Publicado: (2020)

Ignoring SARS-CoV-2 testing performance during COVID-19
por: Buchta, Christoph, et al.
Publicado: (2023)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Positive tracheal SARS-CoV-2 RNA test after three negative SARS-CoV-2 RNA tests in a patient with COVID-19
por: Vigneshwar, Navin G., et al.
Publicado: (2020)

SARS-CoV-2 risk misclassification explains poor COVID-19 management
por: Hernández, Juan Martínez
Publicado: (2020)

Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2
por: Song, Min, et al.
Publicado: (2020)

Absence of SARS-CoV-2 RNA in COVID-19-associated intestinal endothelialitis
por: Stahl, Klaus, et al.
Publicado: (2021)

Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020)

Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect
por: Drak Alsibai, Kinan, et al.
Publicado: (2020)

Aerosol Transmission of SARS-CoV-2: Inhalation as well as Exhalation Matters for COVID-19
por: Philip, Keir E. J., et al.
Publicado: (2021)

High Incidence of Nosocomial Infections in COVID-19 Patients: Is SARS-CoV-2 the Culprit?
por: Rouzé, Anahita, et al.
Publicado: (2021)

Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19
por: Ceulemans, Laurens J, et al.
Publicado: (2021)

Importance score of SARS-CoV-2 genome predicts the death risk of COVID-19
por: Cui, Chunmei, et al.
Publicado: (2022)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

The proximal origin of SARS-CoV-2
por: Andersen, Kristian G., et al.
Publicado: (2020)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tm5ut7r2eqmc8h96kc58mnlm8k